Free Trial
LON:AVO

Advanced Oncotherapy (AVO) Share Price, News & Analysis

Advanced Oncotherapy logo

About Advanced Oncotherapy Stock (LON:AVO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
1.75
1.75
52-Week Range
N/A
Volume
200,000 shs
Average Volume
1.27 million shs
Market Capitalization
£9.50 million
P/E Ratio
N/A
Dividend Yield
5.49%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Advanced Oncotherapy and its competitors with MarketBeat's FREE daily newsletter.

AVO Stock News Headlines

AVO.L Regulatory News
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
Advanced Oncotherapy Share Chat
Advanced Oncotherapy PLC AVO
See More Headlines

AVO Stock Analysis - Frequently Asked Questions

Advanced Oncotherapy plc (LON:AVO) issued its quarterly earnings results on Monday, June, 29th. The company reported ($9.83) EPS for the quarter, missing analysts' consensus estimates of ($8.90) by $0.93.

Shares of AVO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Advanced Oncotherapy investors own include UK Oil & Gas (UKOG), Academy Sports and Outdoors (ASO), Renishaw (RSW), Tullow Oil (TLW), BMR Group (BMR), Lancashire (LRE) and Sirius Minerals (SXX).

Company Calendar

Last Earnings
6/29/2020
Today
7/26/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
Agriculture
Current Symbol
LON:AVO
CIK
N/A
Fax
N/A
Employees
3,900
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£32.60 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-67.34%
Return on Assets
-11.73%

Debt

Debt-to-Equity Ratio
98.71
Current Ratio
1.26
Quick Ratio
0.13

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
33.50
Book Value
GBX 14 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
542,570,000
Free Float
N/A
Market Cap
£9.50 million
Optionable
Not Optionable
Beta
0.06
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (LON:AVO) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners